High silver levels in some period pants could pose health risk, study says Women warned to consider potential effect of wearing brands that contain notably higher quantities of metal The Guardian - UK · Nov 13, 2023
Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients The Independent UK · Nov 11, 2023
The FDA proposes banning a food additive that's been used for a century Brominated vegetable oil is a food additive that studies show causes organ damage in rats and pigs. It was introduced in the 1920s and is used today in sodas and sports drinks. WEKU · Nov 3, 2023
Popular nasal decongestant found to be ineffective by US drugs regulator – what it means for the UK An advisory panel of the US Food and Drug Administration has found that a drug used in the majority of cold and flu products to treat blocked noses does not work. The Conversation · Oct 20, 2023
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said. Fortune · Oct 2, 2023
TikTok videos promoting steroid use have millions of views, says report criticized by the company A report released by a tech watchdog group says TikTok has become a key marketing channel for vendors that want to promote steroids and other bodybuilding drugs to millions of the app's users The Independent UK · Sep 28, 2023
US FDA approves new COVID vaccine: Here’s everything you need to know The US Food and Drug Administration (FDA) has taken cognizance of the COVID situation and has approved the use of updated COVID vaccines. The vaccines have been authorized "for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences… The Times of India · Sep 15, 2023
What to know about Prime, the Logan Paul drink that Sen. Schumer wants investigated Prime drinks have become a Gen Z status symbol, a prized social media prop for a certain brand of teen male. But they're causing jitters among pediatricians who say they pack scary caffeine levels. WEKU · Jul 11, 2023
New blood test can detect high blood pressure in moms during pregnancy The US Food and Drug Administration has approved a blood test that can identify pregnant women at risk of developing high blood pressure, the NYTimes reported. This condition, called as pre-eclampsia, is one of the leading causes of death among women. "The new test may offer an early warning, identifying… The Times of India · Jul 6, 2023
3 Pharma Stocks Every Investor Should Know The pharma sector is poised to witness significant growth due to the widespread adoption of generic medicines and emerging technologies. Therefore, fundamentally strong pharma stocks Pfizer (PFE), Sanofi (SNY), and Spero Therapeutics (SPRO) might be solid buys. Read on. StockNews.com · Jun 15, 2023
RSV: we finally have a vaccine for this deadly virus The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older. The Conversation · May 9, 2023
State lawmakers across US pass 1 abortion ban but 2 defeated With measures to protect abortion access becoming law in two states, a ban in a third state and court action elsewhere, the status of abortion law in the U.S. remains unsettled The Independent UK · Apr 28, 2023
Vermont passes bills aimed at protecting abortion pills The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone The Independent UK · Apr 27, 2023
Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limbo Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and science itself have increased during the COVID-19 pandemic. The Conversation · Apr 26, 2023
Tribune News Service · Apr 11, 2023 US seeks freeze on Texas abortion pill ruling, clarity on conflicting order WASHINGTON — The Biden administration asked a federal appeals court to suspend a ruling by a conservative U.S. judge in Texas that would block access nationwide to a key drug used in medication abortions — even as it sought clarity on a conflicting order in Washington state.
StockNews.com · Mar 29, 2023 3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…
StockNews.com · Mar 7, 2023 4 Stocks to Buy in Any Market Climate The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…
StockNews.com · Mar 2, 2023 2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why.
WEKU · Feb 21, 2023 The maker of Enfamil recalls 145,000 cans of infant formula over bacteria risks Reckitt says despite contamination fears, the recalled formula tested negative for Cronobacter, which can cause rare but deadly infections in infants. Here's how to identify and prevent them.
StockNews.com · Feb 20, 2023 3 Stocks You Won't Have Regrets About Buying in 2023 January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…
StockNews.com · Feb 6, 2023 The Most Active Stocks to Buy on Wall Street This Week Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….
StockNews.com · Feb 3, 2023 3 Stocks to Buy if You're Building a Portfolio From Scratch Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient demand of these companies. Continue reading….
Al Jazeera · Jan 25, 2023 Pro-abortion rights advocates sue over state pill restrictions The lawsuit comes as Republican-led states in the US attempt to crack down on the use of abortion-inducing medications.
The Times of India · Jan 24, 2023 Coronavirus: US proposes annual COVID shots COVID vaccinations are likely to become an annual shot in the US. The US Food and Drug Administration on Monday have proposed to make COVID jabs like an annual flu shot. This, reports say, is a simplified approach for future vaccination efforts and will help in a better vaccination coverage…
The Independent UK · Jan 6, 2023 New hope for Alzheimer’s sufferers as FDA gives fast-track approval to experimental drug The study also showed that Leqembi carries a risk of brain swelling and bleeding